Present status of the efficacy and tolerability of terbinafine (Lamisil) used systemically in the treatment of dermatomycoses of skin and nails
- 1 January 1990
- journal article
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 1 (sup2) , 33-38
- https://doi.org/10.3109/09546639009089029
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- In vitro activity of terbinafineClinical and Experimental Dermatology, 1989
- The successful treatment of finger Trichophyton rubrum onychomycosis with oral terbinafineClinical and Experimental Dermatology, 1989
- Successful treatment of chronic tinea pedis (moccasin type) with terbinafine (Lamisil)Clinical and Experimental Dermatology, 1989
- Clinical pharmacokinetics of terbinafine (Lamisil)Clinical and Experimental Dermatology, 1989
- Activity of terbinafine in experimental fungal infections of laboratory animalsAntimicrobial Agents and Chemotherapy, 1987
- Antifungal activity of the allylamine derivative terbinafine in vitroAntimicrobial Agents and Chemotherapy, 1987
- Teratogenicity in vitro—A comparative study of four antimycotic drugs using the whole-embryo culture systemToxicology in Vitro, 1987
- In-vitro studies with SF 86–327, a new orally active allylamine derivativeMedical Mycology, 1985
- Synthesis and antifungal activity of (E)-N-(6,6-dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethanamine (SF 86-327) and related allylamine derivatives with enhanced oral activityJournal of Medicinal Chemistry, 1984